Cargando…
Omarigliptin Mitigates 6-Hydroxydopamine- or Rotenone-Induced Oxidative Toxicity in PC12 Cells by Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Actions
Dipeptidyl peptidase-4 (DPP-4) inhibitors are reported to exhibit promising effects on several pathological processes associated with Parkinson’s disease (PD). To explore its repositioning potential as an antiparkinsonian agent, we evaluated the effects of omarigliptin (OMG), a DPP-4 inhibitor recen...
Autores principales: | Gouda, Noha A., Cho, Jungsook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598347/ https://www.ncbi.nlm.nih.gov/pubmed/36290663 http://dx.doi.org/10.3390/antiox11101940 |
Ejemplares similares
-
Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress
por: Elsherbeny, Mohamed H., et al.
Publicado: (2021) -
Neuroprotective effects of olanzapine against rotenone-induced toxicity in PC12 cells
por: Xiong, Ya-jie, et al.
Publicado: (2020) -
Memory-Enhancing Effects of Mangosteen Pericarp Water Extract through Antioxidative Neuroprotection and Anti-Apoptotic Action
por: Oh, Yeonsoo, et al.
Publicado: (2020) -
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
por: Ayoub, Bassam M., et al.
Publicado: (2018) -
Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
por: Mnich, Katarzyna, et al.
Publicado: (2010)